Global Pet Insect Repellent Market Size study & Forecast, by Pet Type (Dog, Cat, Birds, and Other Animals), Insect Type (Ticks, Flies, Bees, Fleas, and Other Insect Type), By End User/Application (Pet Clinic, Pet Shops, and Other End Users) and Regional A

Global Pet Insect Repellent Market Size study & Forecast, by Pet Type (Dog, Cat, Birds, and Other Animals), Insect Type (Ticks, Flies, Bees, Fleas, and Other Insect Type), By End User/Application (Pet Clinic, Pet Shops, and Other End Users) and Regional Analysis, 2022-2029

Global Pet Insect Repellent Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.4% over the forecast period 2022-2029. Pet Insect Repellent is a substance applied on pets to protect them from the insect which can cause infection and diseases to them. The Pet Insect Repellent market is expanding because of factors such as an increase in the number of pet owners, increase in vector-borne diseases and increased expenditure on pet health. This market is dominated by Zoetis Inc., Elanco Animal Health, The Hartz Mountain Corporation, Boehringer Ingelheim, and PetIQ LLC.

The growth in diseases such as Vector-borne diseases are transmission by parasites that affect dogs and cats, such as ticks, bees, flies, and fleas. It can be easily used to humans and pets. Many vector-borne diseases such as ehrlichiosis, Lyme disease, relapsing fever, Rocky Mountain spotted fever, and tularemia can be transmitted by ticks worldwide. Among all insects, fleas and ticks are the main types of insects that harm pets and together, they will hold the largest share at 63.8% in 2021. Therefore, flea and tick repellents account for the largest share. According to the American Pet Products Association (APPA), dog owners in the United States had the expenditure of an average $1,880 per dog in the last 12 months on pet food, treats, toys, vitamins, grooming, veterinary visits, and more. According to the European Pet Food Federation (FEDIAF), about 38% of all households in the EU have pets. About 81 million cats, 71 million dogs and 1 billion other pets are domesticated in these households. For this reason, the demand for pet insect repellant has been driven throughout these years. In addition, the rising demand for diagnostic imaging procedures and supplements to prevent diseases is expected to create an opportunity for this market in the forthcoming years. However, the stringent regulations and toxicity in the chemical’s stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pet Insect Repellent Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing health awareness for pets. For instance, more than 85 million American households own one or more pets, with dogs being the overwhelming majority, according to a study by the American Pet Products Association (APPA) and the National Pet Owner Survey (2019-20).
Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising adoption of stray cats and dogs, an increase in the number of collaborations for the betterment of animal health issues, geographic expansion of key players plays a major role, and active support of the government in the market space.

Major market player included in this report are:
Boehringer Ingelheim International GmbH
Vibrac India
Zoetis Inc.
Central Garden & Pet Company
Elanco Animal Health Incorporated
Merck And Co. Inc.
The Hartz Mountain Corporation
Tianjin Ringpu Biotechnology Co. Ltd
PetIQ Inc.
Recent Developments in the Market:
 In Septembe2022, Zoetis Inc. acquired Jurox, the leading suppliers and manufacturers of the livestock and pet products, basically in Australia and the United States. The acquisition provides Zoetis with forthcoming growth opportunities in upcoming years, manufacturing capabilities and enhanced capabilities in the Australian animal health market.
 In August 2020, Elanco Health Corporation announced they have successfully acquired the Bayer Animal Health. Now, Bayer's pet repellent became a part of Elanco's portfolio.
 In July 2020, Boehringer Ingelheim released NexGard and Broadline in India for comprehensive parasite control among the pets. Their two of the products, NexGard and Broadline, offer the most comprehensive parasite treatment.

Global Pet Insect Repellent Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Pet Type, Insect Type, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:

By Pet Type:
Dogs
Cats
Birds
Other Animals
By Insect Type:
Ticks
Flies
Bees
Fleas
Other Insect Type
By End User:
Pet Clinic
Pet Shops
Other End Users

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Boehringer Ingelheim International GmbH
Vibrac India
Zoetis Inc.
Central Garden & Pet Company
Elanco Animal Health Incorporated
Merck And Co. Inc.
The Hartz Mountain Corporation
Tianjin Ringpu Biotechnology Co. Ltd
PetIQ Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.